Grenada vs Vanuatu: The number of people with susceptibility test result for rifampicin
Grenada
0
in 2021
Vanuatu
0
in 2021
Grenada rank
146th
Vanuatu rank
146th
The number of people with susceptibility test result for rifampicin over time
- Grenada
- Vanuatu
How they compare
Grenada currently reports 0 against 0 in Vanuatu, a difference of 0.
Across all 5 years both countries report, Vanuatu has been ahead every year.
Grenada ranks 146th and Vanuatu ranks 146th of 155 countries.
Vanuatu has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Grenada | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.6667 | 46.33 | 45.67 | Vanuatu |
| 2020s | 0 | 21.5 | 21.5 | Vanuatu |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Grenada or Vanuatu?
- Grenada, at 0 against 0 in Vanuatu as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Grenada and Vanuatu?
- 0, with Grenada ahead.
- How many years of comparable data are there for Grenada and Vanuatu?
- 5 years are reported by both, from 2017 to 2021.
- How do Grenada and Vanuatu rank globally for the number of people with susceptibility test result for rifampicin?
- Grenada ranks 146th and Vanuatu ranks 146th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.